Clinical Trial Update: IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features

View source ↗

Summary

This clinical trial update notes an ongoing study evaluating intensity-modulated radiotherapy (IMRT) alone for stage I nasopharyngeal carcinoma without high-ris…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Qiaojuan Guo | Conditions: Nasopharyngeal Cancinoma (NPC), Intensity-modulated Radiotherapy | Status: RECRUITING